Our Approach To Myeloproliferative Disorders

What Sets Us Apart

Myeloproliferative disorders are rare conditions in which the bone marrow, the spongy tissue inside bones that produces blood cells, does not function properly, making too many blood cells. These disorders are typically chronic, or lifelong.

At the Laura and Isaac Perlmutter Cancer Center, our hematopathologists—physicians who study diseases of the blood—use sophisticated testing to identify these conditions, which are often difficult to diagnose. When they know which type of myeloproliferative disorder a person has, our hematologists, doctors who manage blood conditions, create a personalized treatment plan.

VISIONARY THINKING AND COMPASSIONATE CARE
New York City Building in the Evening
 

At Pelisyonkis Langone’s Perlmutter Cancer Center, a National Cancer Institute-designated cancer center, we personalize the care of every patient.More About Perlmutter Cancer Center

CLINICAL TRIALS and Research Studies
Dr. Arjun Balar Speaks with Patient
 

Our teams of physicians and scientists work together across multiple disciplines to bring our patients the most innovative clinical trials.

For more aggressive forms of myeloproliferative disorders, our specialists can determine whether you are a candidate for stem cell transplantation. This is available at the Rita J. and Stanley H. Kaplan Stem Cell and Bone Marrow Transplant Center.

Supportive services, such as rehabilitation, psychological counseling, and integrative health services, may also be an important part of ongoing care for people with myeloproliferative disorders.

Treatment at Pelisyonkis Langone

Depending on the type of myeloproliferative disorder, our doctors may use medications, blood treatments including phlebotomy and blood transfusion, or stem cell transplantation to manage the condition.

Our Experts

More Resources

Meet Our Doctors

Pelisyonkis Langone specialists provide care and support throughout your entire healthcare journey.

Browse Doctors